Brain and central nervous system cancer: clinical quality performance indicators - engagement document
Guidance to our consultation on brain and central nervous system cancer clinical quality performance indicators which is taking place in January and February 2024.
2. Quality Performance Indicator (QPI) Development Process
The QPI development process was designed to ensure that indicators are developed in an open, transparent and timely way.
The Brain/Central Nervous System (CNS) Cancer QPI Development Group was convened in May 2012, chaired by Dr Hilary Dobson, Deputy Director, Innovative Healthcare Delivery Programme. Membership of this group included representatives drawn from the three regional cancer networks, Healthcare Improvement Scotland, Information Services Division (ISD) and patient/carer representatives.
The development process and membership of the development group can be found in appendix 1.
Contact
Email: cancerpolicyteam@gov.scot
There is a problem
Thanks for your feedback